1. Home
  2. PKE vs DBVT Comparison

PKE vs DBVT Comparison

Compare PKE & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$37.51

Market Cap

796.7M

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$15.67

Market Cap

948.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKE
DBVT
Founded
1954
2002
Country
United States
France
Employees
125
90
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
796.7M
948.8M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
PKE
DBVT
Price
$37.51
$15.67
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$32.04
AVG Volume (30 Days)
412.0K
300.6K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
1.53%
N/A
EPS Growth
93.10
10.26
EPS
0.56
N/A
Revenue
N/A
$5,636,000.00
Revenue This Year
N/A
$35.04
Revenue Next Year
N/A
$2,360.78
P/E Ratio
$68.27
N/A
Revenue Growth
N/A
35.77
52 Week Low
$15.23
$8.51
52 Week High
$39.55
$26.19

Technical Indicators

Market Signals
Indicator
PKE
DBVT
Relative Strength Index (RSI) 61.05 40.74
Support Level $31.16 $12.63
Resistance Level $38.20 $17.78
Average True Range (ATR) 2.01 1.09
MACD 0.57 0.07
Stochastic Oscillator 73.09 19.33

Price Performance

Historical Comparison
PKE
DBVT

About PKE Park Aerospace Corp.

Park Aerospace Corp is an aerospace company that develops and manufactures composite materials used to produce composite structures for the aerospace market. Its products include film adhesives, lightning strike protection materials, specialty ablative materials for rocket motors and nozzles, and materials for radome applications. The Company offers composite materials designed for hand lay-up and automated fiber placement (AFP) manufacturing applications, which are used in jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles (UAVs), business jets, general aviation aircraft, and rotary wing aircraft. It operates in North America, Asia, and Europe, with North America generating maximum revenue.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: